Diffusion Pharmaceuticals is Biotechnology in United States that focus on Diffusion Pharmaceuticals Inc business. Founded in 2001. They cover business area such as Diffusion Pharmaceuticals Inc, cancer patient, care, radiation therapy, chemotherapy, trans sodium crocetinate, TSC, glioblastoma multiforme, GBM, metastatic brain cancer, geographically business activity.
2001
( 23 years old in 2024 )
Diffusion Pharmaceuticals Inc
-
1317 Carlton Avenue
Suite 200
Charlottesville, VA 22902
United States
Private
Diffusion Pharmaceuticals Inccancer patientcareradiation therapychemotherapytrans sodium crocetinateTSCglioblastoma multiformeGBMmetastatic brain cancergeographically business activity
* We use standard office opening hours in near Diffusion Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Diffusion Pharmaceuticals is Biotechnology business from United States that founded in 2001 (23 years old in 2024), Diffusion Pharmaceuticals business is focusing on Diffusion Pharmaceuticals Inc.
Diffusion Pharmaceuticals headquarter office and corporate office address is located in 1317 Carlton Avenue Suite 200 Charlottesville, VA 22902 United States.
Diffusion Pharmaceuticals was founded in United States.
In 2024, Diffusion Pharmaceuticals is currently focus on Diffusion Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Diffusion Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Diffusion Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
